Home › Funds › AQR CAPITAL MANAGEMENT LLC › BSX

AQR CAPITAL MANAGEMENT LLC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

AQR CAPITAL MANAGEMENT LLC reported holding 24,324,215 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$1.06B, representing 0.31% of its reported portfolio and ranking #47 among its reported holdings. AQR CAPITAL MANAGEMENT LLC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)24.32M sh
Reported value held$1.06B
Portfolio Weight0.31%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How AQR CAPITAL MANAGEMENT LLC's BSX position evolved

AQR CAPITAL MANAGEMENT LLC first disclosed a stake in BSX in Q3 2023 at 537,152 shares (US$28.4M). The position peaked in Q3 2026 at 24,324,215 shares, worth US$1.06B. Across 13 filings, AQR CAPITAL MANAGEMENT LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 24,324,215 shares valued at US$1.06B — an increase of 14,642,465 shares quarter over quarter.. Notable position changes include a 377% increase in Q1 2026 (shares fell 32% over the following quarter), a 85% increase in Q2 2026 (shares rose 2% over the following quarter), a 151% increase in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 537.15K $28.36M New
Q4 2023 811.11K $46.44M Add
Q1 2024 853.69K $58.47M Add
Q2 2024 702.22K $53.90M Reduce
Q3 2024 964.95K $80.35M Add
Q4 2024 911.94K $81.45M Reduce
Q1 2025 1.16M $114.43M Add
Q2 2025 1.84M $197.11M Add
Q3 2025 1.17M $114.41M Reduce
Q4 2025 1.10M $104.67M Reduce
Q1 2026 5.24M $327.28M Add
Q2 2026 9.68M $413.22M Add
Q3 2026 24.32M $1.06B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 19 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has AQR CAPITAL MANAGEMENT LLC held BSX?

AQR CAPITAL MANAGEMENT LLC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is AQR CAPITAL MANAGEMENT LLC's current position in BSX?

As of Q3 2026, AQR CAPITAL MANAGEMENT LLC holds 24.32M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $1.06B, representing 0.31% of its reported portfolio and ranking #47.

Has AQR CAPITAL MANAGEMENT LLC been buying or selling BSX?

In the latest 13F filing (Q3 2026), AQR CAPITAL MANAGEMENT LLC increased its position in BSX. The position peaked in Q3 2026 at 24.32M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.